Q2FY27 Quarterly Result - Dr. Reddy's Laboratories Ltd.

SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826

Q2FY27 Quarterly Result Announced for Dr. Reddy's Laboratories Ltd. Pharmaceuticals company Dr. Reddy's Laboratories announced Q2FY27 results Consolidated Financial Highlights: Total Revenue from Operations stood at Rs 86,978 million for Q2FY27, registering a sequential (QoQ) increase of 7.38% from Rs 80,998 million in Q1FY27, but a year-on-year (YoY) decline of 1.48% compared to Rs 88,283 million in Q2FY26. For H1FY27, total revenue from operations stood at Rs 1,67,976 million, declining by 3.46% YoY from Rs 1,74,004 million in H1FY26. Total Income reached Rs 88,540 million in Q2FY27, representing a sequential increase of 4.73% QoQ over Rs 84,545 million in Q1FY27, but a decrease of 3.26% YoY against Rs 91,522 million in Q2FY26. For H1FY27, Total Income arrived at Rs 1,73,085 million compared to Rs 1,80,146 million in H1FY26, displaying a YoY drop of 3.92%. Profit Before Tax (PBT) was recorded at Rs 12,276 million for Q2FY27, marking a robust turnaround increase of 121.87% QoQ from Rs 5,533 million in Q1FY27, but decreasing by 29.64% YoY against Rs 17,448 million in Q2FY26. For H1FY27, PBT stood at Rs 17,809 million, dropping YoY by 51.21% against Rs 36,498 million in H1FY26. Profit After Tax (PAT) came in at Rs 9,132 million for Q2FY27, showing a sequential escalation of 109.64% QoQ from Rs 4,356 million in Q1FY27, but trailing YoY by 31.69% behind Rs 13,368 million in Q2FY26. For H1FY27, PAT stood at Rs 13,488 million compared to Rs 27,467 million in H1FY26, reflecting a decrease of 50.89% YoY. All this is for information This is not a buy/sell recommendation. SEBI RA – Shubh Consultancy – Sunil Kotak – INH000015826 Thank you, Technofunda24